Hypoaldosteronism secondary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Akshun Kalia (talk | contribs) |
||
Line 14: | Line 14: | ||
*There are no established measures for the secondary prevention of [disease name]. | *There are no established measures for the secondary prevention of [disease name]. | ||
OR | OR | ||
*Effective measures for the secondary prevention of | *Effective measures for the secondary prevention of hypoaldosteronism include: | ||
** | **Low potassium intake | ||
** | **Salt intake of 4gm/day | ||
** | **Avoid drugs affecting the renin angiotensin aldosterone system (RAAS) such as ACE inhibitors, angiotensinogen receptor blocker and potassium sparing diuretics. | ||
==References== | ==References== |
Revision as of 16:43, 21 August 2017
Hypoaldosteronism Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hypoaldosteronism secondary prevention On the Web |
American Roentgen Ray Society Images of Hypoaldosteronism secondary prevention |
Risk calculators and risk factors for Hypoaldosteronism secondary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Overview
There are no established measures for the secondary prevention of [disease name].
OR
Effective measures for the secondary prevention of [disease name] include [strategy 1], [strategy 2], and [strategy 3].
Secondary Prevention
- There are no established measures for the secondary prevention of [disease name].
OR
- Effective measures for the secondary prevention of hypoaldosteronism include:
- Low potassium intake
- Salt intake of 4gm/day
- Avoid drugs affecting the renin angiotensin aldosterone system (RAAS) such as ACE inhibitors, angiotensinogen receptor blocker and potassium sparing diuretics.